Recent reports suggest a possible link between nifedipine (but not diltiazem) and an increased risk of cancer in patients being treated with calcium antagonists. ## METHODS. A total of 1054 postmyocardial infarction patients were divided randomly into those being treated with calcium antagonists
Pharmacokinetics of vincristine in cancer patients treated with nifedipine
โ Scribed by Leone Fedeli; Mariantonietta Colozza; Enrico Boschetti; Isabella Sabalich; Cynthia Aristei; Roberto Guerciolini; Albano Del Favero; Riccardo Rossetti; Maurizio Tonato; Pietro Rambotti; Stephen Davis
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 558 KB
- Volume
- 64
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract The pharmacokinetics of vindesine, vincristine, and vinblastine were investigated in patients with cancer. All drugs were administered rapidly via intravenous injection, and drug levels were determined in serum obtained at intervals after injection by radioimmunoassay. All three drugs e
A combination of actinomycin D and vincristine has been used to treat 92 patients with various kinds of cancer. The best results were obtained in patients with lung cancer, with a n initial response rate of 6096 and an average duration of remission of over 8 months. Some patients with sarcomas and m
The pharmacokinetics of methotrexate (MX) and 7-OH methotrexate (MXOH) was studied in 18 cancer patients treated with 6-hr intravenous (i.v.) infusion of 100 mglkg (A), 80 mglkg preceded by 20 mglkg i.v. loading dose (B), and 70 mg/kg preceded by 30 mglkg i.v. loading dose (C). Simultaneous analysis